Ha YS - Search Results

1

Expression of phosphorylated p21-activated kinase 4 is associated with aggressive histologic characteristics and poor prognosis in patients with surgically treated renal cell carcinoma.

Kang HW, Piao XM, Lee HY, Kim K, Seo SP, Ha YS, Kim YU, Kim WT, Kim YJ, Lee SC, Kim WJ, Shin EY, Kim EG, Yun SJ. Kang HW, et al. Among authors: ha ys. Investig Clin Urol. 2021 Jul;62(4):399-407. doi: 10.4111/icu.20200399. Epub 2021 May 17. Investig Clin Urol. 2021. PMID: 34085786 Free PMC article.

2

Methylation of the RUNX3 promoter as a potential prognostic marker for bladder tumor.

Kim EJ, Kim YJ, Jeong P, Ha YS, Bae SC, Kim WJ. Kim EJ, et al. Among authors: ha ys. J Urol. 2008 Sep;180(3):1141-5. doi: 10.1016/j.juro.2008.05.002. Epub 2008 Jul 18. J Urol. 2008. PMID: 18639281

3

Clinical implications and prognostic values of topoisomerase-II alpha expression in primary non-muscle-invasive bladder cancer.

Kim EJ, Lee YS, Kim YJ, Kim MJ, Ha YS, Jeong P, Lee OJ, Kim WJ. Kim EJ, et al. Among authors: ha ys. Urology. 2010 Jun;75(6):1516.e9-13. doi: 10.1016/j.urology.2009.08.055. Epub 2009 Nov 13. Urology. 2010. PMID: 19913893

4

Phosphaturia as a promising predictor of recurrent stone formation in patients with urolithiasis.

Ha YS, Tchey DU, Kang HW, Kim YJ, Yun SJ, Lee SC, Kim WJ. Ha YS, et al. Korean J Urol. 2010 Jan;51(1):54-9. doi: 10.4111/kju.2010.51.1.54. Epub 2010 Jan 21. Korean J Urol. 2010. PMID: 20414412 Free PMC article.

5

Sodium restriction as initial conservative treatment for urinary stone disease.

Yun SJ, Ha YS, Kim WT, Kim YJ, Lee SC, Kim WJ. Yun SJ, et al. Among authors: ha ys. J Urol. 2010 Oct;184(4):1372-6. doi: 10.1016/j.juro.2010.06.019. Epub 2010 Aug 17. J Urol. 2010. PMID: 20723924

6

GSTT1 as a prognosticator for recurrence and progression in patients with non-muscle-invasive bladder cancer.

Ha YS, Yan C, Lym MS, Jeong P, Kim WT, Kim YJ, Yun SJ, Lee SC, Moon SK, Choi YH, Kim WJ. Ha YS, et al. Dis Markers. 2010;29(2):81-7. doi: 10.3233/DMA-2010-0729. Dis Markers. 2010. PMID: 21045267 Free PMC article.

7

HMOX1 is an important prognostic indicator of nonmuscle invasive bladder cancer recurrence and progression.

Yim MS, Ha YS, Kim IY, Yun SJ, Choi YH, Kim WJ. Yim MS, et al. Among authors: ha ys. J Urol. 2011 Feb;185(2):701-5. doi: 10.1016/j.juro.2010.09.081. Epub 2010 Dec 18. J Urol. 2011. PMID: 21168882

8

GSTM1 tissue genotype as a recurrence predictor in non-muscle invasive bladder cancer.

Ha YS, Yan C, Jeong P, Kim WT, Yun SJ, Kim IY, Moon SK, Kim WJ. Ha YS, et al. J Korean Med Sci. 2011 Feb;26(2):231-6. doi: 10.3346/jkms.2011.26.2.231. Epub 2011 Jan 24. J Korean Med Sci. 2011. PMID: 21286014 Free PMC article.

9

PFKFB4 as a prognostic marker in non-muscle-invasive bladder cancer.

Yun SJ, Jo SW, Ha YS, Lee OJ, Kim WT, Kim YJ, Lee SC, Kim WJ. Yun SJ, et al. Among authors: ha ys. Urol Oncol. 2012 Nov-Dec;30(6):893-9. doi: 10.1016/j.urolonc.2010.08.018. Epub 2011 Mar 10. Urol Oncol. 2012. PMID: 21396842

10

Expectant Management of Ureter Stones: Outcome and Clinical Factors of Spontaneous Passage in a Single Institution's Experience.

Tchey DU, Ha YS, Kim WT, Yun SJ, Lee SC, Kim WJ. Tchey DU, et al. Among authors: ha ys. Korean J Urol. 2011 Dec;52(12):847-51. doi: 10.4111/kju.2011.52.12.847. Epub 2011 Dec 20. Korean J Urol. 2011. PMID: 22216398 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

276 results

Search Page